NCT02295813View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of FBF001

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2012

Conditions

Avian Influenza

Interventions

BIOLOGICAL

FBF001

DRUG

Placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Fab'entech

INDUSTRY